medigraphic.com
ISSN 0016-3813 (Impreso)

2012, Número 3

<< Anterior Siguiente >>

Gac Med Mex 2012; 148 (3)


Recurrencia tardía del tumor de células de la granulosa: presentación de un caso

Ortega RAT, Pérez Montiel GMD, Martínez MM, Serrano OJA, Cantú LD

Idioma: Español
Referencias bibliográficas: 33
Paginas: 302-306
Archivo PDF: 572.36 Kb.


RESUMEN

El tumor de células de la granulosa del ovario es una neoplasia poco frecuente caracterizada por una historia natural larga, generalmente de buen pronóstico y con capacidad de recurrencia tardía.
Presentamos el caso de una mujer con tumor de células de la granulosa tipo adulto, que desarrolló recurrencia tardía con afección del ovario contralateral, diseminación intraabdominal y metástasis hepáticas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Segal R, DePetrillo AD, Thomas G. Clinical review of adult granulosa cell tumors of the ovary. Gynecol Oncol. 1995;56:338-44.

  2. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21:1180-9.

  3. Jamieson S, Fuller PJ. Management of granulosa cell tumor of the ovary. Curr Opin Oncol. 2008;20:560-4.

  4. Colombo N, Parma G, Zanagnolo V, Insinga A. Management of ovarian stromal cell tumors. J Clin Oncol. 2007;25:2944-51.

  5. Rha SE, Oh SN, Jung SE, Lee YJ, Lee AW, Byun JY. Recurrent ovarian granulosa cell tumors: clinical and imaging features. Abdom Imaging. 2008;33:119-25.

  6. Miller BE, Barron BA, Wan JY, Delmore JE, Silva EG, Gersherson DM. Prognostic factors in adult granulosa cell tumor of the ovary. Cancer. 1997;79:1951-5.

  7. Ayhan A, Salman MC, Velipasaoglu M, Sakinci M, Yuce K. Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases. Gynecol Oncol. 2009;20:158-63.

  8. Sehouli J, Drescher F, Mustea A, et al. Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients. Anticancer Res. 2004;24:1223-30.

  9. Li W, Wu X, Fang CQ, Yao JF, Guo Y, Zhang SL. Prognostic factors in adult granulosa cell tumor of the ovary. Saudi Med J. 2009;30: 247-52.

  10. Lauszus FF, Petersen AC, Greisen J, Jacobsen A. Granulosa cell tumor of the ovary: a population-based study of 37 women with stage I disease. Gynecol Oncol. 2001;81:456-60.

  11. Lee YK, Park NH, Kim JW, Song YS, Kang SB, Lee HP. Characteristics of recurrence in adult-type granulosa cell tumor. Int J Gynecol Cancer. 2008;18:642-7.

  12. Nosov V, Silva I, Tavassoli F, Adamyan L, Farias-Eisner R, Schwartz PE. Predictors of recurrence of ovarian granulosa cell tumors. Int J Gynecol Cancer. 2009;19:628-33.

  13. Mom CH, Engelen MJ, Willemse PH, Gietema JA, Ten Hoor KA, De Vries EG. Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort. Gynecol Oncol. 2007;105(2):365-72.

  14. Robertson DM, Cahir N, Burger HG, et al. Combined inhibin and CA 125 assays in the detection of ovarian cancer. Clin Chem. 1999;45(5):651-8.

  15. Huang YT, Lee JC, Kumar AS. Variable F-18 fluorodeoxyglucose avidity of metastatic recurrent adult granulosa cell tumor. Clin Nucl Med. 2009;34:710-2.

  16. Raj G, Proietto A, Jaaback K. Positron emission tomography and granulosa cell tumor recurrence: a report of 2 cases. Int J Gynecol Cancer. 2009;19:1542-4.

  17. Zhang M, Cheung MK, Shin JY, et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary – An analysis of 376 women. Gynecol Oncol 2007;104:396-400.

  18. Villella J, Herrmann FR, Kaul S, Lele S, Marchetti D, Natiella J. Clinical and pathological predictive factors in women with adult-type granulosa cell tumor of the ovary. Int J Gynecol Pathol. 2007;26(2):154-9.

  19. Pautier P, Lhommé C, Culine S, et al. Adult granulose-cell tumor of the ovary: a retrospective study of 45 cases. Int J Gynecol Cancer. 1997;7:58-65.

  20. Auranen A, Sundström J, Ijäs J, Grénman S. Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature. Int J Gynecol Cancer. 2007;17:1011-8.

  21. Malmström H, Högberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol. 1994;52: 50-5.

  22. Evans AT, Gaffey TA, Malkasian GD, Annegers JF. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol. 1980;55:231-8.

  23. Uygun K, Aydiner A, Saip P. Granulosa cell tumor of the ovary: retrospective analysis of 45 cases. Am J Clin Oncol. 2003;26(5):517-21.

  24. Piura B, Nemet D, Yanai-Inbar I, Cohen Y, Glezerman M. Granulosa cell tumor of the ovary: a study of 18 cases. J Surg Oncol. 1994;55:71-7.

  25. Chan JK, Zhang J, Kaleb V, et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary – A multivariative analysis. Gynecol Oncol. 2005;96:204-9.

  26. Pectasides D, Papaxoinis G, Fountzilas G, et al. Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG). Anticancer Res. 2008;28:1421-8.

  27. Margolin KA, Park HY, Esensten ML, Doroshow JH. Hepatic metastasis in granulosa cell tumor of the ovary. Cancer. 1985;56:691-5.

  28. Gersherson DM, Copeland LJ, Kavanagh J, Stringer CA, Saul PB, Wharton JT. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin and cyclophosphamide. Obstet Gynecol. 1987; 70:765-9.

  29. Pectasides D, Alevizakos N, Athanassiou AE. Cisplatin-containing regimen in advanced or recurrent granulosa cell tumor of the ovary. Ann Oncol. 1992;3:316-8.

  30. Pecorelli S, Wagenaar HC, Vergote IB, et al. Cisplatin (C), vinblastin (V), and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa (theca) cell tumors of the ovary. An EORTC Gynaecological Cancer Cooperative Group study. Eur J Cancer. 1999;35:1331-7.

  31. Homesley HD, Bundy BN, Hurteau JA, Roth LM. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group Study. Gynecol Oncol. 1999;72:131-7.

  32. Bown J, Shvartsman HS, Deavers MT, Burke TW, Munsell MF, Gersherson D. The activity of taxanes in the treatment of sex cord-stromal ovarian tumors. J Clin Oncol. 2004;22:3517-23.

  33. Brown J, Shvartsman HS, Deavers MT, et al. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol. 2005;97:489-96.




2020     |     www.medigraphic.com